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In preparation for monitoring of vaccine-induced
responses, we determined HIV-specific cell-mediated
immune responses in 17 treatment naïve HIV-1 infected
individuals with > 400 CD4+ T cells/ml for at least 5 years
including 9 patients with low viral load (VL, < 5000 cop-
ies/ml) and 8 with high VL (> 5000 copies/ml). HIV-1
specific IFN-γ-production and cytolytic activity were
higher in subjects with low VL. The differences between
the two groups were statistically significant for CD4+ T-
cell responses to Gag and Nef peptides, tested by a long-
term (48 h) ICS assay and of border-line significance for
the Gag-specific cytolytic responses measured by a flow-
cytometry assay and a chromium release assay. We also
found a significant inverse correlation between VL and
IFN-γ-production by CD8+ T-cells in response to Gag as
measured by ICS. The ELISpot IFN-γ response was not sig-
nificantly different in patients with high and low VL. Dur-
ing a median follow-up period of 2.4 years, 6 of 8 subjects
with high VL and 1 of 9 with low VL showed decreasing
CD4+ T-cell counts, and ARV treatment was more fre-
quently initiated in the former patient group (5 of 8 versus
1 of 9). The CD4 and CD8 T cell immune responses found
to be associated with low VL and stable CD4 counts may
be of importance for protection.
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